RhumbLine Advisers’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$591K Sell
82,103
-469
-0.6% -$3.01K ﹤0.01% 2505
2025
Q4
$466K Sell
82,572
-11,709
-12% -$63.5K ﹤0.01% 2704
2025
Q3
$582K Sell
94,281
-7,888
-8% -$46.1K ﹤0.01% 2589
2025
Q2
$498K Buy
102,169
+62,747
+159% +$222K ﹤0.01% 2687
2025
Q1
$146K Sell
39,422
-4,255
-10% -$18.2K ﹤0.01% 3268
2024
Q4
$175K Buy
43,677
+4,161
+11% +$22.9K ﹤0.01% 3263
2024
Q3
$275K Buy
39,516
+5,743
+17% +$46.6K ﹤0.01% 3069
2024
Q2
$191K Buy
+33,773
New +$302K ﹤0.01% 3244
2024
Q1
Hold
0
4247
2023
Q4
Hold
0
4265
2023
Q3
Sell
-27
Closed -$105 4305
2023
Q2
$146 Buy
+27
New +$152 ﹤0.01% 4363
2022
Q2
Sell
-4,777
Closed -$86K 3220
2022
Q1
$86K Sell
4,777
-483
-9% -$8.52K ﹤0.01% 2914
2021
Q4
$138K Buy
5,260
+286
+6% +$8.74K ﹤0.01% 2901
2021
Q3
$178K Buy
4,974
+112
+2% +$4.76K ﹤0.01% 2926
2021
Q2
$267K Buy
4,862
+2,525
+108% +$167K ﹤0.01% 2829
2021
Q1
$194K Buy
2,337
+4
+0.2% +$443 ﹤0.01% 2839
2020
Q4
$265K Buy
2,333
+444
+24% +$28.1K ﹤0.01% 2719
2020
Q3
$58K Sell
1,889
-470
-20% -$18K ﹤0.01% 2939
2020
Q2
$104K Buy
2,359
+582
+33% +$24.2K ﹤0.01% 2961
2020
Q1
$64K Buy
1,777
+50
+3% +$2.47K ﹤0.01% 2839
2019
Q4
$115K Buy
1,727
+138
+9% +$15.2K ﹤0.01% 2862
2019
Q3
$247K Buy
1,589
+272
+21% +$30.8K ﹤0.01% 2667
2019
Q2
$114K Buy
1,317
+304
+30% +$33.2K ﹤0.01% 2909
2019
Q1
$140K Sell
1,013
-30
-3% -$7.52K ﹤0.01% 2813
2018
Q4
$419K Buy
1,043
+382
+58% +$180K ﹤0.01% 2380
2018
Q3
$468K Buy
661
+89
+16% +$55.9K ﹤0.01% 2306
2018
Q2
$306K Buy
+572
New +$176K ﹤0.01% 2522

Other funds holding SLDB